盈康生命 reported revenue of ¥1.02B for the period ended 2026-06-30, +20.6% year on year. Net income was ¥0.08B, a 8.1% net margin on a 28.4% gross margin. The largest revenue line is 医疗服务 at 81% of the total. Free cash flow for the period was ¥0.18B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.02B | +20.6% |
| Gross profit | ¥0.29B | — |
| Operating income | ¥0.11B | — |
| Net income | ¥0.08B | +33.5% |
| Gross margin | 28.4% | Net margin 8.1% |
| Revenue Q/Q | +4.7% | — |
| Segment | Revenue | Share |
|---|---|---|
| 医疗服务 | ¥0.82B | 80.9% |
| 医疗器械 | ¥0.19B | 19.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.73B | 71.6% |
| R&D | ¥0.03B | 2.7% |
| SG&A | ¥0.14B | 14.0% |
| Tax & other | ¥0.03B | 2.8% |
| Item | Amount |
|---|---|
| Total assets | ¥4.00B |
| Total liabilities | ¥1.56B |
| Shareholders' equity | ¥2.44B |
| Equity / assets | 61.1% |
| Operating cash flow | ¥0.20B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥0.18B |
| Cash conversion (OCF / net income) | 349% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
宋城演艺 ・ 南方泵业 ・ 汤臣倍健 ・ *ST香雪 ・ 天舟文化 ・ 睿智医药 ・ 世纪瑞尔 ・ 昌红科技 ・ *ST动力 ・ 科泰电源 ・ 瑞凌股份 ・ 安居宝
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies